Published in Infect Immun on November 01, 1978
Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev (1998) 8.36
Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea. Infect Immun (1981) 3.69
Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin. Proc Natl Acad Sci U S A (1979) 3.17
Identification and preliminary characterization of Vibrio cholerae outer membrane proteins. J Bacteriol (1981) 2.58
In vivo and in vitro characterization of virulence-deficient mutants of Vibrio cholerae. Infect Immun (1979) 2.50
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice. Infect Immun (1981) 2.39
In vivo evaluation of pathogenicity of clinical and environmental isolates of Vibrio cholerae. Infect Immun (1980) 1.28
rfb mutations in Vibrio cholerae do not affect surface production of toxin-coregulated pili but still inhibit intestinal colonization. Infect Immun (1999) 1.12
Development of an enzyme-linked immunosorbent assay for studying Vibrio cholerae cell surface antigens. J Clin Microbiol (1982) 1.12
Kinetics of early cholera infection in the removable intestinal tie-adult rabbit diarrhea model. Infect Immun (1982) 1.03
Ability of an avirulent mutant of Vibrio cholerae to colonize in the infant mouse upper bowel. Infect Immun (1981) 1.02
Plasmid-mediated changes in virulence of Vibrio cholerae. Infect Immun (1986) 0.99
Quantitative determination of bacterial replication in vivo. Infect Immun (1985) 0.91
Comparison of in vivo and in vitro multiplication rates of Haemophilus influenzae type b. Infect Immun (1986) 0.78
Motility as a virulence factor for Vibrio cholerae. Infect Immun (1975) 6.67
Adhesive properties of Vibrio cholerae: adhesion to isolated rabbit brush border membranes and hemagglutinating activity. Infect Immun (1976) 5.86
Adhesive properties of Vibrio cholerae: nature of the interaction with intact mucosal surfaces. Infect Immun (1976) 5.36
Microbial growth rates in nature. Bacteriol Rev (1971) 5.24
The fate of bacteria in the small intestine. J Pathol Bacteriol (1960) 4.91
The nature of the gastrointestinal lesion in asiatic cholera and its relation to pathogenesis: a biopsy study. Am J Trop Med Hyg (1960) 4.45
Distribution of cholera organisms in experimental Vibrio cholerae infections: proposed mechanisms of pathogenesis and antibacterial immunity. Infect Immun (1976) 4.40
Antibacterial mechanisms of the mouse gut. I. Kinetics of infection by Salmonella typhi-murium in normal and streptomycin-treated mice studied with abortive transductants. Br J Exp Pathol (1963) 3.54
Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice. Infect Immun (1977) 3.35
Intestinal fluid and electrolyte transport in human cholera. J Clin Invest (1970) 3.09
Biochemistry of Vibrio cholerae virulence. 3. Nutritional requirements for toxin production and the effects of pH on toxin elaboration in chemically defined media. Infect Immun (1973) 3.04
A method for quantitating intrapulmonary bacterial inactivation in individual animals. J Lab Clin Med (1966) 2.69
Mechanisms of disease and immunity in cholera: a review. J Infect Dis (1977) 2.17
Intestinal distribution of Vibrio cholerae in orally infected infant mice: kinetics of recovery of radiolabel and viable cells. Infect Immun (1978) 1.89
Interactions between mechanisms controlling the intestinal microflora. Am J Clin Nutr (1974) 1.74
Studies on immunity to Asiatic cholera. VIII. The virulence of strains of Vibrio cholerae for the mouse. J Infect Dis (1957) 1.72
Antibody cross-linking as a factor in immunity to cholera in infant mice. J Infect Dis (1975) 1.61
Antibacterial mechanisms in the intestine. Elimination of V. cholerae from the intestines of infant mice and the role of antibody. Aust J Exp Biol Med Sci (1975) 1.46
Binding of cholera toxin to mucins and inhibition by gastric mucin. Infect Immun (1974) 1.39
A new test for the identification of roughness in Vibrio cholerae. Indian J Med Res (1951) 1.28
Protection against cholera. A bactericidal mechanism on the mucosal surface of the small intestine of mice. Aust J Exp Biol Med Sci (1975) 1.20
Re-examination of small intestinal disposal of Vibrio cholerae in mice. Aust J Exp Biol Med Sci (1977) 1.01
BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J Med Chem (2000) 2.74
Identification and preliminary characterization of Vibrio cholerae outer membrane proteins. J Bacteriol (1981) 2.58
In vivo and in vitro characterization of virulence-deficient mutants of Vibrio cholerae. Infect Immun (1979) 2.50
Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae. Infect Immun (1984) 2.42
Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint. Am J Med (2001) 2.36
Isolation and characterization of protease-deficient mutants of vibrio cholerae. J Infect Dis (1978) 2.19
Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am J Obstet Gynecol (1990) 2.15
Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir. Antimicrob Agents Chemother (2001) 2.00
Effect of pyridines on phenotypic properties of Bordetella pertussis. Infect Immun (1982) 1.92
Intestinal distribution of Vibrio cholerae in orally infected infant mice: kinetics of recovery of radiolabel and viable cells. Infect Immun (1978) 1.89
Cloning of the filamentous hemagglutinin of Bordetella pertussis and its expression in Escherichia coli. Infect Immun (1987) 1.69
Rapid identification of Staphylococcus aureus in blood cultures by thermonuclease testing. J Clin Microbiol (1983) 1.57
Isolation and characterization of the fertility factor P of Vibrio cholerae. J Bacteriol (1973) 1.56
Isolation and phenotypic characterization of virulence-deficient mutants of Vibrio cholerae. Infect Immun (1978) 1.53
A comparison of nonculture-dependent methods for detection of Chlamydia trachomatis infections in pregnant women. Obstet Gynecol (1987) 1.49
Interaction of monoclonal antibodies with pertussis toxin and its subunits. Infect Immun (1984) 1.40
In vivo evaluation of pathogenicity of clinical and environmental isolates of Vibrio cholerae. Infect Immun (1980) 1.28
Bordetella pertussis major outer membrane porin protein forms small, anion-selective channels in lipid bilayer membranes. J Bacteriol (1986) 1.25
Purification and characterization of the mucinase of Vibrio cholerae. J Infect Dis (1982) 1.23
Pertussis outbreak in Austin and Travis County, Texas, 1975. J Clin Microbiol (1977) 1.17
Isolation and characterization of monoclonal antibodies to Bordetella pertussis. J Biol Stand (1984) 1.15
Identification and characterization of Vibrio cholerae surface proteins by radioiodination. Infect Immun (1985) 1.15
Heat-modifiable envelope proteins of Bordetella pertussis. Infect Immun (1986) 1.10
Antibiotic susceptibility testing of Bordetella pertussis. Am J Clin Pathol (1980) 1.09
Comparison of two commercially available isolation systems for Chlamydia trachomatis. J Clin Microbiol (1983) 1.08
Aspergillosis in gamebirds and ducks. Vet Rec (2011) 1.07
Ability of an avirulent mutant of Vibrio cholerae to colonize in the infant mouse upper bowel. Infect Immun (1981) 1.02
Surface proteins of Bordetella pertussis: comparison of virulent and avirulent strains and effects of phenotypic modulation. Infect Immun (1986) 1.02
Identification and occurrence of Vibrio cholerae flagellar core proteins in isolated outer membrane. Infect Immun (1985) 0.99
Plasmid-mediated changes in virulence of Vibrio cholerae. Infect Immun (1986) 0.99
Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)--a novel potent and orally active immunosuppressive agent. Int Immunopharmacol (2001) 0.96
Murine antibody response to oral infection with live aroA recombinant Salmonella dublin vaccine strains expressing filamentous hemagglutinin antigen from Bordetella pertussis. Infect Immun (1990) 0.95
Effects of fatty acids on growth of Bordetella pertussis in defined medium. J Clin Microbiol (1979) 0.95
Susceptibility of Pseudomonas paucimobilis to 24 antimicrobial agents. Antimicrob Agents Chemother (1983) 0.94
Evaluation of a ribosomal vaccine against pertussis. Infect Immun (1979) 0.93
The accuracy and patient preference for self-collected group B Streptococcus cultures. Am J Obstet Gynecol (1995) 0.92
NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community. Diabetes (1995) 0.91
Nocardiosis in recipients of renal transplants: evidence for nosocomial acquisition. Am J Infect Control (1986) 0.91
Characterization of Vibrio cholerae protease activities with peptide digest analysis. J Clin Microbiol (1981) 0.90
Variability in derivative strains of Bordetella pertussis. Dev Biol Stand (1980) 0.90
PET imaging of cardiac hypoxia: opportunities and challenges. J Mol Cell Cardiol (2011) 0.89
Characterization of intestinal brush border guanylate cyclase activation by Escherichia coli heat-stable enterotoxin. Arch Biochem Biophys (1986) 0.89
Function of solids in anaerobic lagoon treatment of wastewater. J Water Pollut Control Fed (1968) 0.87
Differential centrifugation separates cardiac sarcolemmal and endosomal membranes from Langendorff-perfused rat hearts. Anal Biochem (2001) 0.86
Pneumonia due to Aeromonas hydrophila-complex: epidemiologic, clinical, and microbiologic features. South Med J (1988) 0.86
Structural requirements for major histocompatibility complex class II invariant chain endocytosis and lysosomal targeting. J Biol Chem (1998) 0.84
Isolation and characterization of the Vibrio cholerae recA gene. J Bacteriol (1986) 0.84
Analysis of charges associated with diagnosis of nosocomial pneumonia: can routine bronchoscopy be justified? J Trauma (1994) 0.84
Analysis of the structural requirements for lysosomal membrane targeting using transferrin receptor chimeras. J Biol Chem (1998) 0.83
Penile incarceration secondary to a ring. Urol Int (2010) 0.83
Cell surface antigens of Bordetella pertussis. Dev Biol Stand (1985) 0.81
Surface antigens of Bordetella pertussis. Adv Exp Med Biol (1985) 0.81
Beta-lactamase testing of staphylococci in a commercial broth microdilution minimum inhibitory concentration system. J Clin Microbiol (1982) 0.81
Regulation of intestinal mucosa guanylate cyclase by hemin, heme and protoporphyrin IX. Biochim Biophys Acta (1987) 0.79
Reversal of the biological activity of Escherichia coli heat-stable enterotoxin by disulfide-reducing agents. Infect Immun (1986) 0.79
Solubilization and reprecipitation from intestinal brush border membranes of a complex containing guanylate cyclase activatable by the heat-stable enterotoxin. Arch Biochem Biophys (1991) 0.78
Future fitness of female insect pests in temporally stable and unstable habitats and its impact on habitat utility as refugees for insect resistance management. J Insect Sci (2009) 0.78
Age-dependent changes in affinity-labeled receptors for Escherichia coli heat-stable enterotoxin in the swine intestine. Infect Immun (1991) 0.77
Activation of intestinal brush border guanylate cyclase by aromatic disulphide compounds. Biochem J (1991) 0.76
Differential uptake of FDG and DG during post-ischaemic reperfusion in the isolated, perfused rat heart. Eur J Nucl Med (1999) 0.76
An evaluation of two rapid bacteriuria screening procedures. Obstet Gynecol (1987) 0.76
Nucleotide regulation of heat-stable enterotoxin receptor binding and of guanylate cyclase activation. Biochem J (1992) 0.75
The radiographic assessment and subsequent management of unerupted teeth. Br J Orthod (1974) 0.75
Subcellular fractions for immunizing against pertussis. Dev Biol Stand (1978) 0.75
The provision of orthodontic care in the National Health Service in England and Wales. Trans Eur Orthod Soc (1974) 0.75
Cryogenic solvents inhibit the binding of the Escherichia coli heat-stable enterotoxin to intestinal brush border membranes. Arch Biochem Biophys (1993) 0.75
[Bilateral cleft lip and palate, surgical repositioning of the premaxilla: comparative study]. Mondo Ortod (1988) 0.75
Mixing of 10-microm radiation in room-temperature Schottky diodes. Opt Lett (1981) 0.75
Variations in the treatment of bilateral clefts of lip and palate. Rep Congr Eur Orthod Soc (1967) 0.75
A pilot study to assess the validity of the Orthodontic Treatment Priority Index in English schoolchildren. Community Dent Oral Epidemiol (1974) 0.75
Falsely high values for chloride in serum containing myeloma proteins, measured in the Paramax. Clin Chem (1988) 0.75
Orthodontics in the general dental services (a review of its aims, methods and achievements). Br J Orthod (1986) 0.75
Modelling of control options for an outbreak of Mycoplasma gallisepticum in egg production: a decision support tool. Vet J (2013) 0.75
Pseudoepidemic of salmonellosis in a nursery: importance of isolate serotyping. Am J Infect Control (1987) 0.75
[Postsurgical family information: an improvement area. Prospective study after urologic surgery]. Actas Urol Esp (2010) 0.75
Contract negotiation. The basics. Comput Nurs (1997) 0.75
Hospital and community orthodontic services in Leicestershire. A report on co-operation between services. Br Dent J (1975) 0.75
Effect of jejunal loop location on the activity of Escherichia coli heat-stable enterotoxin in 4- to 5-week-old pigs. Am J Vet Res (1987) 0.75
'The great debate'. Br Dent J (1989) 0.75
Multiband appliances. Dent Pract Dent Rec (1966) 0.75
Bar coding technology and its applications in emergency care. J Emerg Nurs (1996) 0.75